353 related articles for article (PubMed ID: 28283772)
1. Identification, genetic testing, and management of hereditary melanoma.
Leachman SA; Lucero OM; Sampson JE; Cassidy P; Bruno W; Queirolo P; Ghiorzo P
Cancer Metastasis Rev; 2017 Mar; 36(1):77-90. PubMed ID: 28283772
[TBL] [Abstract][Full Text] [Related]
2. Melanoma genetics.
Read J; Wadt KA; Hayward NK
J Med Genet; 2016 Jan; 53(1):1-14. PubMed ID: 26337759
[TBL] [Abstract][Full Text] [Related]
3. Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):411-20; quiz 421-2. PubMed ID: 26892651
[TBL] [Abstract][Full Text] [Related]
4. Management of familial melanoma and nonmelanoma skin cancer syndromes.
Santillan AA; Cherpelis BS; Glass LF; Sondak VK
Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for cancer predisposition.
Eng C; Hampel H; de la Chapelle A
Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
[TBL] [Abstract][Full Text] [Related]
6. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
Levin T; Mæhle L
Fam Cancer; 2017 Apr; 16(2):257-265. PubMed ID: 27804060
[TBL] [Abstract][Full Text] [Related]
7. Molecular landscape of Hereditary Melanoma.
Ribeiro Moura Brasil Arnaut J; Dos Santos Guimarães I; Evangelista Dos Santos AC; de Moraes Lino da Silva F; Machado JR; de Melo AC
Crit Rev Oncol Hematol; 2021 Aug; 164():103425. PubMed ID: 34245855
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
9. Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD,
Pastorino L; Andreotti V; Dalmasso B; Vanni I; Ciccarese G; Mandalà M; Spadola G; Pizzichetta MA; Ponti G; Tibiletti MG; Sala E; Genuardi M; Chiurazzi P; Maccanti G; Manoukian S; Sestini S; Danesi R; Zampiga V; La Starza R; Stanganelli I; Ballestrero A; Mastracci L; Grillo F; Sciallero S; Cecchi F; Tanda ET; Spagnolo F; Queirolo P; Italian Melanoma Intergroup (IMI) ; Goldstein AM; Bruno W; Ghiorzo P
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325837
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer predisposition syndromes.
Hemel D; Domchek SM
Hematol Oncol Clin North Am; 2010 Oct; 24(5):799-814. PubMed ID: 20816575
[TBL] [Abstract][Full Text] [Related]
11. Familial skin cancer syndromes: Increased melanoma risk.
Ransohoff KJ; Jaju PD; Tang JY; Carbone M; Leachman S; Sarin KY
J Am Acad Dermatol; 2016 Mar; 74(3):423-34; quiz 435-6. PubMed ID: 26892652
[TBL] [Abstract][Full Text] [Related]
12. Melanoma susceptibility genes and risk assessment.
Marzuka-Alcalá A; Gabree MJ; Tsao H
Methods Mol Biol; 2014; 1102():381-93. PubMed ID: 24258989
[TBL] [Abstract][Full Text] [Related]
13. Update in genetic susceptibility in melanoma.
Potrony M; Badenas C; Aguilera P; Puig-Butille JA; Carrera C; Malvehy J; Puig S
Ann Transl Med; 2015 Sep; 3(15):210. PubMed ID: 26488006
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to ocular melanoma.
Houlston RS; Damato BE
Eye (Lond); 1999; 13 ( Pt 1)():43-6. PubMed ID: 10396383
[TBL] [Abstract][Full Text] [Related]
15. Familial Melanoma: Diagnostic and Management Implications.
Rossi M; Pellegrini C; Cardelli L; Ciciarelli V; Di Nardo L; Fargnoli MC
Dermatol Pract Concept; 2019 Jan; 9(1):10-16. PubMed ID: 30775140
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing for melanoma predisposition: current challenges.
Gerstenblith MR; Goldstein AM; Tucker MA; Fraser MC
Cancer Nurs; 2007; 30(6):452-9; quiz 462-3. PubMed ID: 18025917
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing by cancer site: skin.
Gabree M; Seidel M
Cancer J; 2012; 18(4):372-80. PubMed ID: 22846740
[TBL] [Abstract][Full Text] [Related]
18. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Chen LM; Richardson DL;
Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
[TBL] [Abstract][Full Text] [Related]
19. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
[TBL] [Abstract][Full Text] [Related]
20. Clinical germline genetic testing for melanoma.
Hansen CB; Wadge LM; Lowstuter K; Boucher K; Leachman SA
Lancet Oncol; 2004 May; 5(5):314-9. PubMed ID: 15120668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
